<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00695474</url>
  </required_header>
  <id_info>
    <org_study_id>M-20080061</org_study_id>
    <nct_id>NCT00695474</nct_id>
  </id_info>
  <brief_title>Vitamin D and Type 2 Diabetes - a Cross Sectional Study</brief_title>
  <official_title>Vitamin D and Type 2 Diabetes - a Cross Sectional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regionshospitalet Silkeborg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to describe vitamin D status among patients with type 2 diabetes
      and to determine the association between serum 25-hydroxyvitamin D and glycemic control,
      markers of inflammation and blood pressure
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It has been estimated that 1 billion people worldwide have vitamin D deficiency or
      insufficiency. It is well known that vitamin D deficiency causes osteoporosis, increases the
      risk of fracture and causes muscle weakness. But there is now evidence that calcium
      malnutrition and hypovitaminosis D are predisposing conditions for various common chronic
      diseases such as malignancies (particularly colon, breast and prostate) chronic inflammatory
      and autoimmune disease (inflammatory bowel disease, multiple sclerosis) as well as metabolic
      disorders (metabolic syndrome, hypertension).

      It has also been reported that vitamin D deficiency may predispose to glucose intolerance,
      altered insulin secretion and type 2 diabetes mellitus.

      The purpose of this study is to determine vitamin D status among type 2 diabetics in our
      outpatient clinic and examine the relationship between vitamin D status , calcium and
      phosphorous metabolism, inflammatory markers, glycemic control, blood pressure and lipid
      profile.

      Moreover the patients are asked to answer a questionnaire regarding lifestyle, exercise, sun
      exposure and food intake.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vitamin D status and its association with inflammation, glycemic control, lipids and blood pressure.</measure>
    <time_frame>December 08</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lifestyle (exercise, sun exposure, food intake)</measure>
    <time_frame>December 08</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">150</enrollment>
  <condition>Hypovitaminosis D</condition>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <description>The cohort consists of type 2 diabetics from the outpatient clinic at Silkeborg Hospital.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples, urine.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists of Danish type 2 diabetics from the outpatient clinic at
        Silkeborg Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes mellitus

          -  Patients of Danish extraction

          -  Written consent

        Exclusion Criteria:

          -  Renal failure (Urea &gt; 12 mmol/l)

          -  Age &lt; 18 years

          -  malabsorption
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lotte Oeskov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Department, Silkeborg Hospital, Falkevej 1-3, 8600 Silkeborg, Denmark</affiliation>
  </overall_official>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2008</study_first_submitted>
  <study_first_submitted_qc>June 9, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2008</study_first_posted>
  <last_update_submitted>July 10, 2009</last_update_submitted>
  <last_update_submitted_qc>July 10, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 14, 2009</last_update_posted>
  <responsible_party>
    <name_title>MD, Med. Sci. Lotte Oerskov</name_title>
    <organization>Medical Department, Silkeborg Hospital</organization>
  </responsible_party>
  <keyword>Hypovitaminosis D</keyword>
  <keyword>Type 2 diabetes</keyword>
  <keyword>Glycemic control</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Blood pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Avitaminosis</mesh_term>
    <mesh_term>Rickets</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

